Neurobiology of Migraine (R01)
National Institutes of Health · Opportunity PA-07-305
Multiple Receipt Dates - See Link to Full Announcement for details.
Who can apply
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities
- Native American tribal organizations (other)
- Nonprofits with 501(c)(3), other than higher education
- Nonprofits without 501(c)(3)
- Private institutions of higher education
- For-profit organizations other than small businesses
- Small businesses
- Others
Foreign institutions are eligible to apply.
About this opportunity
-Purpose. This Funding Opportunity Announcement (FOA) is a program announcement (PA) issued by the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH). It solicits R01 grant applications from institutions/organizations that intend to perform innovative research that will expand our current knowledge of neurobiological mechanisms underlying the phases of migraine and the role of neuromodulators such as sex hormones, and genetic influences in migraine pathophysiology. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism and runs in parallel with an FOA of identical scientific scope, PA-07-306, Neurobiology of Migraine (R21) , that solicits applications under the NIH Exploratory/Developmental Grant (R21) award mechanism. -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Similar grants still open
| Opportunity | Agency | Deadline | Award ceiling | Eligible |
|---|---|---|---|---|
| Environmental Health Sciences Core Centers Program (P30 Clinical Trials Optional) | National Institutes of Health | April 20, 2027 | — | Nonprofits |